Addition of fibrates to simvastatin therapy in hyperlipidaemic patients
- 31 December 1992
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 97, S67-S71
- https://doi.org/10.1016/0021-9150(92)90166-e
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Influence of lovastatin plus gemfibrozil on plasma lipids and lipoproteins in patients with heterozygous familial hypercholesterolemia.Circulation, 1989
- Efficacy and long-term adverse effect pattern of lovastatinThe American Journal of Cardiology, 1988
- Effects of lovastatin alone and in combination with cholestyramine on serum lipids and apolipoproteins in heterozygotes for familial hypercholesterolemiaAtherosclerosis, 1988
- Combination treatment with cholestyramine and bezafibrate for heterozygous familial hypercholesterolaemia.BMJ, 1988
- HMG-CoA Reductase Inhibitors for Treatment of HypercholesterolemiaNew England Journal of Medicine, 1988
- Rhabdomyolysis in Patients Receiving Lovastatin after Cardiac TransplantationNew England Journal of Medicine, 1988
- Myolysis and Acute Renal Failure in a Heart-Transplant Recipient Receiving LovastatinNew England Journal of Medicine, 1988
- Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert PanelArchives of internal medicine (1960), 1988
- Change in very low‐, low‐, and high‐density lipoproteins during lipid lowering (bezafibrate) therapy: studies in type IIA and type IIb hyperlipoproteinaemiaEuropean Journal of Clinical Investigation, 1986
- Effect of bezafibrate during 4.5 years of treatment of hyperlipoproteinaemiaAtherosclerosis, 1985